Flamels systems, Micropump for small molecules and Medusa for proteins, allow improvements in the therapeutic characteristics, safety profile and patient compliance of many drugs.

The Company is a recognized world leader in the innovation of delivery systems for small molecule and protein drugs, providing tailored solutions to the biotech and pharmaceutical industries for optimized controlled-release delivery of drugs.

Flamel has partnership agreements with major pharmaceutical companies.